Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Understanding neuropathic pain.

Walter Zieglgänsberger1, Achim Berthele, Thomas R Tölle

  • 1Department of Clinical Neuropharmacology, Max Planck Institute of Psychiatry, Kraepelinstrasse 2, 80804 Munich, Germany. wzg@mpipsykl.mpg.de

CNS Spectrums
|March 25, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Factors Associated With Disability Improvement and Worsening Independent of Attacks in Patients With AQP4-IgG+ NMOSD and MOGAD: A Multicenter Cohort Study.

Neurology·2026
Same author

Unmet needs in the care of patients with neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody associated disease: insights from Germany.

Neurological research and practice·2026
Same author

Sex-specific analysis of early disease course and treatment in a German multiple sclerosis cohort.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

Meningococcal prophylaxis in neurological diseases treated with complement inhibitors: an expert consensus for Germany, Austria, and Switzerland.

Therapeutic advances in neurological disorders·2026
Same author

Socioeconomic impact of depression and pain in patients with neuromyelitis optica spectrum disorders.

Neurological research and practice·2026
Same author

Author Response: Eculizumab Use in Neuromyelitis Optica Spectrum Disorders: Routine Clinical Care Data From a European Cohort.

Neurology·2026
Same journal

Qualitative Clock-Drawing Errors Across Dementia Etiologies and Mild Cognitive Impairment: A Clinically Interpretable Six-Class Framework.

CNS spectrums·2026
Same journal

Correlation patterns between lifetime mood spectrum, impulsivity, and disordered eating behaviors in candidates to bariatric surgery.

CNS spectrums·2026
Same journal

Do patients and clinicians agree on the essential features of OCD?

CNS spectrums·2026
Same journal

Treatment Instability in Generalized Anxiety Disorder (GAD): A U.S. Real-World Evidence Study.

CNS spectrums·2026
Same journal

Prevalence, Severity and Correlates of Post-traumatic Stress Disorder in 205 Outpatients with Schizophrenia: Results from a Cross-sectional, Observational Study Assessing Diagnoses via the Mini-International Neuropsychiatric Interview.

CNS spectrums·2026
Same journal

Lithium and long-term cognitive outcomes in bipolar disorder and early dementia: a systematic review.

CNS spectrums·2026
See all related articles

Neuropathic pain arises from nervous system damage, causing chronic pain. New treatments are emerging to target long-term changes in pain pathways, offering hope for better pain management.

Area of Science:

  • Neuroscience
  • Pain Research
  • Pharmacology

Background:

  • Neuropathic pain results from nervous system lesions or dysfunction.
  • Peripheral nerve injury causes increased nociceptor excitability and neurogenic inflammation.
  • Nerve damage releases neurotransmitters like L-glutamate and substance P, triggering central nervous system events.

Purpose of the Study:

  • To explore the mechanisms underlying neuropathic pain.
  • To identify potential targets for novel pain management strategies.
  • To investigate the role of activity-dependent gene expression in chronic pain.

Main Methods:

  • Review of existing literature on neuropathic pain mechanisms.
  • Analysis of neurotransmitter release and cellular events in the central nervous system.

Related Experiment Videos

  • Examination of short-term versus long-term neuronal alterations in pain pathways.

    • Main Results:

    • Neuropathic pain involves peripheral and central nervous system changes, including neurogenic inflammation.
    • Short-term neuronal excitability changes are responsive to conventional analgesics.
    • Long-term alterations in pain pathways may involve activity-dependent gene expression.

    Conclusions:

    • Neuropathic pain is a complex condition involving multiple biological systems.
    • Emerging treatments aim to modulate long-term changes in the pain matrix.
    • Further research into activity-dependent gene expression could lead to innovative pain therapies.